Pure Global
NCT04092231

Outcomes of Cochlear Implantation in Pediatrics

Subjective and Functional Outcome Measures to Evaluate Performance of Pediatric Cochlear Implant
Amira Mohmed Ahmed Bakr·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hearing Impaired Children
Drug/Device/Intervention
Early speech perception test
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
Amira Mohmed Ahmed Bakr
Funder
Assiut University
Timeline & enrollment
Phase
N/A
Start date
May 01, 2020
End date
Dec 30, 2022
Enrollment
30 participants
Primary outcome

change in percent correct in speech perception as measured with single words presented in a closed set

Summary

The cochlear implant (CI) is the most important progress in the treatment for adults and
 children with severe to profound bilateral sensorineural hearing loss who do not receive
 adequa¬te benefit from hearing aids and making possible better results in auditory,
 linguistic, social and academic development.

ICD-10 classifications
Hearing loss, unspecifiedOther hearing lossOther specified hearing lossFamily history of deafness and hearing lossCongenital malformations of ear causing impairment of hearing
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04092231
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04092231 through Pure Global AI's free database. This phase not specified trial is sponsored by Amira Mohmed Ahmed Bakr and is currently Not yet recruiting. The study focuses on Hearing Impaired Children. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.